It is a paper private limited company based in New Delhi, Delhi, India, established in 2023.
2023 | New Delhi, Delhi, India | ActiveZyprus Pharma Private Limited, a active private limited company, was established on 13 June 2023 in New Delhi, Delhi, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002DL2023PTC415673. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Mridula Mehrishi (Director), Rashmani Kumar Mehrishi (Director), Karan Mehrishi (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-78 First Floor, Dda Shed, New Delhi, Delhi, 110020.
U21002DL2023PTC415673
415673
13 June 2023
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Zyprus Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mridula Mehrishi | Director | 13 Jun 2023 | Current |
| Rashmani Kumar Mehrishi | Director | 13 Jun 2023 | Current |
| Karan Mehrishi | Director | 13 Jun 2023 | Current |
| Ashwani Kumar Mehrishi | Director | 13 Jun 2023 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Zyprus Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Zyprus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Zyprus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zyprus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zyprus Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Zyprus Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Zyprus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Progress on Mridula Mehrishi was appointed as a Director was appointed as a Director on 13 Jun 2023 & has been associated with this company since 2 years 5 months . was documented.
Progress on Rashmani Kumar Mehrishi was appointed as a Director was appointed as a Director on 13 Jun 2023 & has been associated with this company since 2 years 5 months . was documented.
Progress on Karan Mehrishi was appointed as a Director was appointed as a Director on 13 Jun 2023 & has been associated with this company since 2 years 5 months . was documented.
Progress on Ashwani Kumar Mehrishi was appointed as a Director was appointed as a Director on 13 Jun 2023 & has been associated with this company since 2 years 5 months . was documented.
The CIN of Zyprus Pharma Private Limited is U21002DL2023PTC415673.
Zyprus Pharma Private Limited is headquartered at C-78 First Floor, Dda Shed, New Delhi, Delhi, 110020.
Zyprus Pharma Private Limited was incorporated on 13 June 2023.
The current directors of Zyprus Pharma Private Limited are
The primary industry of Zyprus Pharma Private Limited is Paper.
Zyprus Pharma Private Limited is unlisted.
The authorized capital of Zyprus Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX